Back in December, consulting firm McKinsey & Company issued an apology for advising Purdue Pharma how to ‘turbocharge’ opioid sales. According to a recent New York Times article, the firm is now putting its money where its mouth is with a massive settlement to the tune of $573 million. The agreement comes after lawsuits from 49 states produced a trove of documents illustrating how McKinsey’s advice to drugmakers contributed to an opioid crisis that claimed 450,000 lives in twenty years.
Another Big Opioid Crisis Settlement
A consulting company will pay nearly $600 million for its role in pushing opioid sales.
Feb 11, 2021
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
